GRAIL Plans to Raise in Excess of $1B in Series B Funding

/0 Comments/in , /by

Investment by Strategic Industry Partners Would Enable GRAIL to Expand Clinical Validation of Blood Test for Early-Stage Cancer Detection SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN), today announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed private and strategic investors. GRAIL intends to raise additional capital […]

Read more →

Synthego Raises $41 Million in Series B Financing Led by 8VC to Advance CRISPR Genome Engineering

/0 Comments/in , /by

Synthego to change the pace of biological research with automation, precision, and machine learning REDWOOD CITY, CA – Synthego, a leading provider of genome engineering solutions, announces today a $41 million Series B financing. Since the company’s founding in 2012, Synthego has raised a total of $50 million. The investment is led by technology venture […]

Read more →

Protein Metrics Inc. Announces Third Year of Record Growth and Change in Leadership

/0 Comments/in , , , /by

SAN CARLOS, Calif. — Protein Metrics Inc., a premier provider of mass spectrometry software for protein characterization, announces a third year of record revenue.  Sales of products doubled from 2015 with due to new customers, increased sales to existing customers, and new products.  New 2016 products include: Supernovo™, a hands-free de novo sequencing software for […]

Read more →

Microsaic Systems Trading Update

/0 Comments/in , /by

Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry (“MS”) instruments, designed to improve the efficiency of pharmaceutical (“Pharma”) R&D, announces a trading update as it approaches its year end. Overview It is expected that EBITDA and pre-tax profit for 2016 will be broadly in line with market expectations at the time of […]

Read more →